000			01509 a2200397 4500
005			20250516115904.0
264		0	_c20130531
008			201305s 0 0 eng d
022			_a2041-4889
024	7		_a10.1038/cddis.2012.155 _2doi
040			_aNLM _beng _cNLM
100	1		_aOrzáez, M
245	0	0	_aIntrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination treatment. _h[electronic resource]
260			_bCell death & disease _cOct 2012
300			_ae415 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCaspase 8 _xgenetics
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCyclin A _xantagonists & inhibitors
650	0	4	_aCyclin-Dependent Kinase 2 _xantagonists & inhibitors
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aDrug Therapy, Combination
650	0	4	_aErlotinib Hydrochloride
650	0	4	_aHumans
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aQuinazolines _xpharmacology
700	1		_aGuevara, T
700	1		_aSancho, M
700	1		_aPérez-Payá, E
773	0		_tCell death & disease _gvol. 3 _gp. e415
856	4	0	_uhttps://doi.org/10.1038/cddis.2012.155 _zAvailable from publisher's website
999			_c22210895 _d22210895